Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Purchase Interest in JV from Danaher

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer today said that it has signed an agreement to purchase from Danaher the remaining interest in a joint venture for Inductively Coupled Plasma Mass Spectrometry (ICP-MS), as well as related assets.

Terms of the acquisition were not disclosed.

Danaher had gained a 50 percent interest in the ICP-MS joint venture through its recent acquisition of MDS Analytical Technologies. The JV makes the ICP-MS technologies that are used for high-sensitivity detection of individual chemical elements in a sample. It is used in the environmental, nutraceutical, biomonitoring, semiconductor, and geochemical research markets, said PerkinElmer.

In December, PerkinElmer had filed a notice of application with the Ontario Superior Court of Justice seeking to block MDS' pending sale of the joint venture to Danaher. It settled the action with MDS last month, but did the firms did not disclose the settlement terms.

PerkinElmer will have full ownership of the JV and the ICP-MS product line once the deal is completed.

"Customers will benefit from our ability to get products to market faster, as well as to better align our offering with market needs," John Roush, president of environmental health for PerkinElmer, said in a statement.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.